Clinical trials: Mercury Poisoning
Mercury Poisoning
NBMI Treatment in Patients With Mercury Toxicity
NBMI (N1, N3-Bis-(2-Mercaptoethyl) Isophthalamide) is a new metal chelator drug proposed as an alternative to the current chelators, and it is widely different; compared to the current chelators, consisting of two cysteamine…
- Trial name
- NBMI-Hg-COL (NCT04183595)
- Testing
- (N1, N3-bis(2- mercaptoethyl)isophthalamide), Excipients microcrystalline cellulose, silica and magnesium stearate
- Where
- Colombia
- Volunteers
- 116 people, healthy volunteers welcome
- Sponsor
- EmeraMed
Mercury Poisoning
Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication
A randomized, placebo controlled, double blind proof of concept study of NBMI in treatment of mercury intoxication.
- Trial name
- NBMI (NCT02486289)
- Testing
- Emeramide
- Where
- Ecuador
- Volunteers
- 36 people
- Sponsor
- EmeraMed